Lecture 25 - Lipid Lowering Therapy Flashcards
Cholesterol Subfractions?
Total cholesterol, LDL cholesterol, HDL cholesterol, Triglycerides
Why lower cholesterol?
primary prevention: vascular events, small contribution to mortality; secondary prevention: large beneficial effects, decreased CVS mortality and morbidity
Clinical assessment?
any organ damage (primary vs. secondary prevention), BP, xanthoma, glucose, fasting fats levels,
Who to treat?
secondary prevention (Angina, MI, CVA, PVD), diabetes, familial hypercholesteraemia primary prevention (CVS risk >30% over 10yr)
Statins effects?
decrease TC, LDL and Trigs, increase HDL e.g. simvastatin
Fibrates?
big decrease of Trigs, increase HDL e.g. Bezafibrate
Other drugs?
Ezetimibe (decrease TC and LDL) and nicotinic acid (decrease trigs)
Statin mechanism of action?
competitive inhibition of HMG CoA reductase: reduce cholesterol synthesis, secondary upregulation of LDL receptor expression hepatocytes -> decrease in circulating LDL (inflammation also decreases), give at night
Statin side effects?
myalgias, myositis, rhabdomyolysis, deranged LFTs
Statin interactions?
Cytochrom P450 (verapamil, diltiazem, erythromycin), fibrate
Myopathy pathology?
mutation of OATP1B1 channel reduces hepatic drug uptake, causing statin blood conc. to increase and effect muscles
Pleiotropic effect?
anti thrombotic, anti inflammatory, immune modulation, benefits before cholesterol drop
Fibrates - indications?
isolated hypertriglyceridaemia (after trying diet and exercise), Resistant hypercholesteraemia (combination w statins)
Fibrates - mechanism of action?
PPARalpha agonist - lincrease liver and muscle lipid metabolism (VLDL production and clearance, FA muscle stores) and activate lipoprotein lipase (break down TGs)
Fibrates - side effects?
GI upset, deranged LFTs, myositis (increased risk w statin)